Стр. 139 - ДИС

Упрощенная HTML-версия

136
J.A. Collins, J.M. Blake, P.G. Crosignani // Human Reproductive Update. –
2005. – Vol. 11, N 6. – P. 545-560.
100
Collins, P. Management of cardiovascular risk in the peri-menopausal woman: a
consensus statement of European cardiologists and gynaecologists / P. Collins,
G. Rosano, C. Casey et al. // European Heart Journal. – 2007. – Vol. 28. – P.
2028-2040.
101
Cooper, C. Osteoporosis: recent advances in pathogenesis and treatment / C.
Cooper, A. Aihie // Quart. J. Med. – 1994. – Vol. 87, N 4. – P. 203-209.
102
Cremoux, P. Controversies concerning the use of phytoestrogens in menopause
management: bioavailability and metabolism / P. Cremoux, P. This, G. Leclercq,
Y. Jacquot // Maturitas. – 2010. – Vol. 65, N 4. – P. 334-339.
103
Cummings, S.R. Epidemiology and outcomes of osteoporotic fractures / S.R.
Cummings, L.J. Melton // Lancet. – 2002. – Vol. 359, N 9319. – P. 1761-1767.
104
Dalais, F.S. Phytoestrogens: Effects on Menopausal Symptoms / F.S. Dalais //
Phytoestrogens and Health / eds. G.S. Gilani, J. Anderson. – Ottawa: AOCS
Press, 2002. – 672 p.
105
Davis, S.R. Drugs for the treatment of menopausal symptoms / S.R. Davis, F.
Jane // Expert Opin Pharmacother. – 2010. – Vol. 11, N 8. – P. 1329-1341.
106
Deanfield, J.E. Endothelial function and dysfunction: testing and clinical
relevance / J.E. Deanfield, J.P. Halcox, T.J. Rabelink // Circulation. – 2007. –
Vol. 115. – P. 1285-1295.
107
Delmas, P.D. Markers of bone turnover for monitoring treatment of osteoporosis
with antiresorptive drugs / P.D. Delmas // Osteoporos Int. – 2000. – Vol. 11. – P.
S66-S76.
108
Delmas, P.D. Monitoring Individual Response to Hormone Replacement
Therapy with Bone Markers / P.D. Delmas, P. Hardy, P. Garnero, M.P. Dain //
Bone. – 2000. – Vol. 26, N 6. – P. 553-560.
109
/ C.E.
//
– 2006. –
Vol. 51, N 6. – P. 402-409.
110
Dietrich, T. Effects of blood estrogen level on cortical activation patterns during
cognitive activation as measured by functional MRI / T. Dietrich, T. Krings, J.
Neulen et al. // Neuroimage. – 2001. – Vol. 13. – P. 425-432.
111
Dubey, R.K. Estrogen-induced cardiorenal protection: potential cellular,
biochemical, and molecular mechanisms / R.K. Dubey, E.K. Jackson // Am J
Physiol Renal Physiol. – 2001. – Vol. 280. – P. F365-F388.
112
Duker, E.M. Effects of extracts from Cimicifuga racemosa on gonadotropin
release in menopausal women and ovariectomized rats / E.M. Duker, L.
Kopanski, H. Jarry et al. // Planta Med. – 1991. – Vol. 57. – P. 424-427.
113
Duncan, A.M. Hormonal Effects of Phytoestrogens in Premenopausal Women /
A.M. Duncan // Phytoestrogens and Health / eds. G.S. Gilani, J. Anderson. –
Ottawa: AOCS Press, 2002. – 672 p.